hidden pixel

H3 Antagonist Information

An H3-receptor antagonist is a classification of drugs used to block the action of histamine at the H3 receptor. Unlike the H1 and H2 receptors which have primarily peripheral actions, but cause sedation if they are blocked in the brain, H3 receptors are primarily found in the brain and are inhibitory autoreceptors located on histaminergic nerve terminals, which modulate the release of histamine. Histamine release in the brain triggers secondary release of excitatory neurotransmitters such as glutamate and acetylcholine via stimulation of H1 receptors in the cerebral cortex. Consequently unlike the H1 antagonist antihistamines which are sedating, H3 antagonists have stimulant and nootropic effects, and are being researched as potential drugs for the treatment of neurodegenerative conditions such as Alzheimer's disease.

Examples of selective H3 antagonists include clobenpropit,[1] ABT-239,[2] ciproxifan,[3] and A-349,821.[4]

References

  1. ^ Yoneyama H, Shimoda A, Araki L, et al. (March 2008). "Efficient approaches to S-alkyl-N-alkylisothioureas: syntheses of histamine H3 antagonist clobenpropit and its analogues". J. Org. Chem. 73 (6): 2096–104. doi:10.1021/jo702181x. PMID 18278935.
  2. ^ Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (2005). "Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist". J. Pharmacol. Exp. Ther. 313 (1): 176–90. doi:10.1124/jpet.104.078402. PMID 15608077.
  3. ^ LLigneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J (November 1998). "Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist". J. Pharmacol. Exp. Ther. 287 (2): 658–66. PMID 9808693.
  4. ^ Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA (1 September 2004). "Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist". Biochemical Pharmacology 68 (5): 933–45. doi:10.1016/j.bcp.2004.05.048. PMID 15294456.
Neuromodulation
Types
Classes
Enzyme see
Ion channel
Receptor & transporter
BA/M
Adrenergic
Dopaminergic
Histaminergic
Serotonergic
AA
GABAergic
Glutamatergic
Cholinergic
Endocannabinoid
Opioid
Other
Miscellaneous
Histaminergics
Receptor ligands
H1
H2
H3
H4
Reuptake inhibitors
Vesicular
VMAT inhibitors
Enzyme inhibitors
Anabolism
HDC inhibitors
Catabolism
HNMT inhibitors
DAO inhibitors
Others
Precursors
Cofactors
Psychostimulants, agents used for ADHD, and nootropics (N06B)
Centrally acting sympathomimetics AmphetamineAmphetaminilAtomoxetineDexmethylphenidateDextroamphetamineDextromethamphetamineFencamfamineFenethyllineLisdexamfetamineMethylphenidateMesocarbPemolinePipradrolProlintane
Xanthine derivatives CaffeineFenethylline
Glutamate receptor
Racetams AniracetamNefiracetamNoopeptOxiracetamPhenylpiracetamPiracetamPramiracetam
Ampakines CX-516CX-546CX-614CX-691CX-717IDRA-21LY-404,187LY-503,430PEPAS-18986SunifiramUnifiram
Eugeroics / Benzhydryl compounds AdrafinilArmodafinilModafinil
Histamine H3 receptor antagonists A-349,821ABT-239CiproxifanGSK-189,254
GABAA α5 inverse agonists α5IAL-655,708PWZ-029SuritozoleTB-21007ZK-93426
Dopamine D1 receptor agonists A-77636DihydrexidineDinapsolineDoxanthrineSKF-812976-Br-APBClozapine
α7 nicotinic agonists / PAMs AR-R17779PNU-282,987SSR-180,711
Prolyl endopeptidase inhibitors S-17092
Alpha-adrenergic agonists ClonidineGuanfacine
Plants Paullinia cupana (Guarana)Eleutherococcus senticosus
Antioxidants Stabilized R-(+)-lipoic acid (RLA)
Other psychostimulants and nootropics AcetylcarnitineAdafenoxateBifemelaneCarbenoxoloneCiticolineCyprodenateEnsaculinIdebenoneIsproniclineDeanolDimebonFipexideLeteprinimLinopirdineMeclofenoxateNizofenoneP7C3PirisudanolPyritinolRubidiumSulbutiamineTaltirelinTricyanoaminopropeneVinpocetinePhosphatidylserineTyrosine

: PSO/PSI

(, , , , , , ), /,

proc(/), drug(/////)

Nootropics (N06B)
Acetylcholinesterases
Ampakines
D1 Agonists
Eugeroics
GABAA α5 Inverse Agonists
H3 Antagonists
mACh Agonists
nACh Agonists
Racetams
Others
Antidepressants (N06A)
Specific reuptake inhibitors (RIs), enhancers (REs), and releasing agents (RAs)
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin–norepinephrine reuptake inhibitors (SNRIs)
Serotonin–norepinephrine–dopamine reuptake inhibitors (SNDRIs)
Norepinephrine reuptake inhibitors (NRIs)
Dopamine reuptake inhibitors (DRIs)
Norepinephrine-dopamine reuptake inhibitors (NDRIs)
Norepinephrine-dopamine releasing agents (NDRAs)
Serotonin-norepinephrine-dopamine releasing agents (SNDRAs)
Selective serotonin reuptake enhancers (SSREs)
Others
Receptor antagonists and/or reuptake inhibitors
Serotonin antagonists and reuptake inhibitors (SARIs)
Noradrenergic and specific serotonergic antidepressants (NaSSAs)
Norepinephrine-dopamine disinhibitors (NDDIs)
Serotonin modulators and stimulators (SMSs)
Others
Heterocyclic antidepressants (bi-, tri-, and tetracyclics)
Bicyclics
Tricyclics
Tetracyclics
Monoamine oxidase inhibitors (MAOIs)
Nonselective
MAOA-Selective
MAOB-Selective
Azapirones and other 5-HT1A receptor agonists

: PSO/PSI

(, , , , , , ), /,

proc(/), drug(/////)

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Categories:

 

The above information uses material from Wikipedia and is licensed under the GNU Free Documentation License.
Some facts may not have been fully verified for accuracy. [Disclaimers]
This page was last archived by our server on Sun Apr 1 17:36:26 2012.
Displaying this page or its contents does not use any Wikimedia Foundation's resources.
The owners of this site proudly support the Wikimedia Foundation.